Shares of Eraaya Lifesciences surged 5% to reach a new all-time high of ₹2,767.40 on the BSE on Tuesday following the company’s announcement regarding the suspension of Robin Raina, Chairman and CEO of Ebix, after its acquisition of the latter.
Subscribe To Our Free Newsletter |